Exploration Capital, LLC - 20 Dec 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital, LLC
Issuer symbol
FRTX
Transactions as of
20 Dec 2023
Net transactions value
+$39,480
Form type
4
Filing time
20 Dec 2023, 20:07:00 UTC
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $39,480 +47,000 $0.8400 47,000 20 Dec 2023 Direct F1, F2, F3
holding FRTX Common Stock 700,000 20 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
F3 These shares are directly owned by Stephen L. Gustin.